The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Open accessAbstract
Inflammasomes are involved in diverse inflammatory diseases, so the activation of inflammasomes needs to be tightly controlled to prevent excessive inflammation. However, the endogenous regulatory mechanisms of inflammasome activation are still unclear. Here, we report that the neurotransmitter dopamine (DA) inhibits NLRP3 inflammasome activation via dopamine D1 receptor (DRD1). DRD1 signaling negatively regulates NLRP3 inflammasome via a second messenger cyclic adenosine monophosphate (cAMP), which binds to NLRP3 and promotes its ubiquitination and degradation via the E3 ubiquitin ligase MARCH7. Importantly, in vivo data show that DA and DRD1 signaling prevent NLRP3 inflammasome-dependent inflammation, including neurotoxin-induced neuroinflammation, LPS-induced systemic inflammation, and monosodium urate crystal (MSU)-induced peritoneal inflammation. Taken together, our results reveal an endogenous mechanism of inflammasome regulation and suggest DRD1 as a potential target for the treatment of NLRP3 inflammasome-driven diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, NLRP3−/− mice were resistant to the loss of nigral dopaminergic neurons induced by treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and this was associated with a reduction in caspase-1 activation and IL-1β and IL-18 secretion (244).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [244]
Citations
Cites
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D. E., & Tipton, K. F. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1883 · Cited by 1,401
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 701–800 of 1,000
Saad, H. M., Salem, E. A., & Elsayed, A. E. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04818-4 · Cited by 11
Xu, Z., Wang, Y., Xie, T., Luo, R., Ni, H., Hang, X., Tang, S., Tan, S., Fang, R., Ran, P., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01710-5 · Cited by 15
Huang, H., Gao, Y., Nie, K., & Wang, L. (2021) · PubMed Central · doi:10.12122/j.issn.1673-4254.2021.07.02 · Cited by 11
Johnson, A. M., Ou, Z.-Y. A., Gordon, R., & Saminathan, H. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106113 · Cited by 11
Towards a multidimensional model of inflamed depression
Wijaya, M. T., Jin, R. R., Liu, X., Zhang, R., & Lee, T. M. C. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100564 · Cited by 12
Ma, M., Zheng, S., Chen, H., Xu, H., Zhang, D.-L., Zhang, Y.-A., Xiang, S., Cheng, B., Jin, S., & Fu, P. (2023) · Laboratory Investigation · doi:10.1016/j.labinv.2022.100028 · Cited by 11
Wang, B., Tian, L., Wu, M., Zhang, D., Yan, X., Bai, M., Li, Y., Su, P., & Xu, E. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112451 · Cited by 12
Su, J., Wang, H., Yang, Y., Wang, J., Li, H., Huang, D., Huang, L., Bai, X., Yu, M., Fei, J., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.06.010 · Cited by 11
Marín‐Aguilar, F., Ruı́z-Cabello, J., & Cordero, M. D. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_13 · Cited by 12
IL‑18 and IL‑35 in the serum of patients with sepsis thrombocytopenia and the clinical significance
Zhu, M., Rong, X., Li, M., & Wang, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8347 · Cited by 11
Ye, X., Han, X., Li, B., Dai, J., Wu, Z., He, Y., Wen, L., & Hu, G. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00354.2019 · Cited by 11
Lv, H., Yan, C., Deng, L., Peng, Z., Yang, D., Hu, W., Ding, X., Tong, C., & Wang, X. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.642913 · Cited by 11
Wu, Z., Han, X., Bao, J., Li, B., Shen, J., Song, P., Peng, Q., Wang, X., & Hu, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4499219 · Cited by 11
NLRP3 inflammasome: activation, regulation, and role in diseases
Zhou, R., Yan, Y., Jiang, W., & Jiang, H. (2017) · Scientia Sinica Vitae · doi:10.1360/n052016-00360 · Cited by 10
Li, H., Jang, J. H., Jung, J., Shin, J., Park, C., Kim, Y.-J., Ahn, W.-G., Nam, J., Hong, C.-W., Lee, J., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700783 · Cited by 11
Neuro-immune axis in atherosclerosis: mechanisms of regulation and therapeutic opportunities
Shang, Y., Pan, Y., Xie, L., Zhao, Y. G., Mao, W., & Chen, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1619338 · Cited by 11
Fu, J., Zong, X., Zhang, H., Zhu, L.-Y., Gong, T., Cheng, Y.-Z., Wang, F.-Q., Lu, Z.-Q., Zhang, C., Jin, M.-L., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116808 · Cited by 12
The iron-dopamine D1 coupling modulates neural signatures of working memory across adult lifespan
Gustavsson, J., Johansson, J. J., Falahati, F., Andersson, M., Papenberg, G., Avelar‐Pereira, B., Bäckman, L., Kalpouzos, G., & Salami, A. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120323 · Cited by 11
Zhang, X., Sun, Q., Quan, Z., Wu, L., Liu, Z., Xia, Y., Wang, Q., Zhang, Y., & Zhu, J. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16226 · Cited by 10
Zhao, Y., Miao, C., Wang, R., Chen, Y., Ren, N., Ma, J., Gao, T., & Zhang, Q. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117796 · Cited by 10
Su, X., Chen, Y., Zhang, Q.-C., Peng, X., Liu, Y., Wang, L., & Du, Y. (2024) · Pancreas · doi:10.1097/mpa.0000000000002351 · Cited by 11
Mai, Z., Han, Y., Dong, L., Mai, F., Zheng, H., Li, P., Li, Y., Ma, C., Chen, Y., Li, W., et al. (2024) · mSystems · doi:10.1128/msystems.01301-23 · Cited by 13
Role of MARCH E3 ubiquitin ligases in cancer development
Behera, A., Sachan, D., Barik, G. K., & Reddy, A. B. M. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10201-x · Cited by 10
Liu, J., Xiao, Y., Xu, Q., Xu, Y., Guo, M., Hu, Y. F., Wang, Y., & Wang, Y. Q. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00986-y · Cited by 10
Ding, M., Ning, C., Chen, S., Yin, H., Xu, J., & Wang, Y. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17320 · Cited by 11
Jin, Z., Lu, J., Xu, H., Zhang, Y., Zhang, S., Zhang, D., Hu, J. S., Shi, Z., Li, Z., & Wang, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117382 · Cited by 10
Zika virus inhibits cell death by inhibiting the expression of NLRP3 and A20
Li, J., Zhu, C., Meng, Y., Zhang, L., Liu, C., Qin, Y., & Chen, M. (2025) · Journal of Virology · doi:10.1128/jvi.01980-24 · Cited by 10
A neuroimmune pathway drives bacterial infection
Wang, N., Liu, J., Wu, R., Chen, F., Zhang, R., Yu, C., Zeh, H. J., Xiao, X., Wang, H., Billiar, T. R., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr2226 · Cited by 11
Cross-talk between NLRP3 and AIM2 inflammasomes in macrophage activation by LPS and titanium ions
Carrillo-Gálvez, A. B., Guerra-Valverde, J. A., Padial‐Molina, M., Martínez-Cuevas, A., Abril‐García, D., Olaechea, A., Martín‐Morales, N., O’Valle, F., Galindo‐Moreno, P., & Zurita, F. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01290-7 · Cited by 10
Beyond neurons: How does dopamine signaling impact astrocytic functions and pathophysiology?
Favetta, G., & Bubacco, L. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102798 · Cited by 11
Li, F., Liu, Z., Xu, Y., Guo, Y. M., Xu, Z., Gongming, Y., Zhao, J., Li, P., Wang, R., Howatson, J., et al. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01209-8 · Cited by 10
Wang, S., Zhu, X., Han, M., Hao, F., Lu, W., & Zhou, T. (2020) · The AAPS Journal · doi:10.1208/s12248-020-0428-5 · Cited by 10
Fawzy, H., Mohammed, A. A., Fawzy, H. M., & Fikry, E. M. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2021-0664 · Cited by 10
Correlation between the dopaminergic system and inflammation disease: a review
Ma, P., & Ou, Y. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08610-2 · Cited by 11
Leal, V. N. C., & Pontillo, A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3350-2_1 · Cited by 10
Meng, J., Cai, Y., Yao, J., & Yan, H. (2024) · Brain and Behavior · doi:10.1002/brb3.3429 · Cited by 10
Jin, J., Li, A., Wang, W., & Wu, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.087 · Cited by 10
Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Beaulieu, J., Borrelli, E., Carlsson, A., Caron, M. G., Civelli, O., Espinoza, S., Fisone, G., Gainetdinov, R. R., Grandy, D. K., Kebabian, J. W., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f20/2019.4 · Cited by 10
Yin, T., Li, Y., Sung, P., Chiang, J. Y., Shao, P., Yip, H., & Lee, M. S.-S. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17620 · Cited by 10
Cyclic dinucleotides modulate human T‐cell response through monocyte cell death
Tosolini, M., Pont, F., Verhoeyen, E., & Fournié, J. (2015) · European Journal of Immunology · doi:10.1002/eji.201545697 · Cited by 10
Regulating against the dysregulation: new treatment options in autoinflammation
Kallinich, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0501-9 · Cited by 10
Luo, H., Liu, N., Lin, C., Luo, H., Xu, L., Wu, W., Liu, N., & Ji, J. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01515-y · Cited by 10
Liang, J.-Y., Yuan, X., Jiang, J., Zhang, P., & Kuang-Tan (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115167 · Cited by 13
Jiang, H., Xie, Y., Hu, Z., Lu, J., Zhang, J., Li, H., Zeng, K., Peng, W., Yang, C., Huang, J., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3002961 · Cited by 9
Exploring the Role of NLRP3 in Neurodegeneration: Cutting‐Edge Therapeutic Strategies and Inhibitors
Mustafa, M. A., Bansal, P., Pallavi, M., Panigrahi, R., Nathiya, D., Kumar, S., Al-Hasnaawei, S., Chauhan, A. S., & Singla, S. (2025) · Developmental Neurobiology · doi:10.1002/dneu.22982 · Cited by 12
Post-translational modifications of NLRP3: to prime or not to prime?
Dufies, O., & Zanoni, I. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.10.008 · Cited by 11
Cerantola, S., Faggin, S., Caputi, V., Bosi, A., Banfi, D., Rambaldo, A., Porzionato, A., Liddo, R. D., De, R., Savarino, E. V., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120562 · Cited by 9
Drugs to Treat Neuroinflammation in Neurodegenerative Disorders
Wang, Y., Kung, W., Chung, Y., & Kumar, S. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230403125140 · Cited by 9
Lubec, J., Hussein, A. M., Kalaba, P., Feyissa, D. D., Arias‐Sandoval, E., Cybulska-Kłosowicz, A., Bezu, M., Stojanovic, T., Korz, V., Maliković, J., et al. (2023) · Biomolecules · doi:10.3390/biom13030467 · Cited by 9
Yang, M., Teng, G., Li, G., Huang, T., & Xu, R. (2018) · International Journal of Pharmacology · doi:10.3923/ijp.2018.1169.1178 · Cited by 9
Yang, Y., Liu, Y.-P., Bao, W., Chen, J.-S., & Xi, X. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.71 · Cited by 9
Chovar, O., López, E., Gálvez‐Cancino, F., Prado, C. E., Demane, D. F., Figueroa, D. A., Espinoza, A., Figueroa, C. A., Lladser, Á., & Pacheco, R. (2022) · Cells · doi:10.3390/cells11223536 · Cited by 8
Chen, X., Wei, J., Zhang, Y., Zhang, Y., & Zhang, T. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.122889 · Cited by 10
Role of NLRP3 Inflammasomes in Neurodegenerative Diseases
Demirtaş, N., Mazlumoğlu, B. Ş., & Palabıyık, Ş. S. (2023) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2023.23349 · Cited by 8
Unveiling Parkinson’s disease through biomarker research: current insights and future prospects
Çelik, N. D., Özben, S., & Özben, T. (2024) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2024.2331471 · Cited by 8
Li, X., Li, W., Zang, C., Yan, J., Cai, M., Liu, Z., Cai, R., Gao, Y., & Qi, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155985 · Cited by 8
Yin, X., Li, G., Ji, F., Wang, M., Gao, Y., Li, F., Wang, Z., Han, G., & Gao, Z. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04560-3 · Cited by 9
Afzal, M., Hameed, H., Paiva‐Santos, A. C., Saleem, M., Hameed, A., & Ahmad, S. M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177199 · Cited by 8
Sadier, N. S., Hazimeh, I. A., Khazaal, W., Sabouri, A. A. K. A., Almutary, A. G., Alnuqaydan, A. M., & Abbas, L. A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01733-x · Cited by 9
Jeon, S., Kang, J., & Lee, S. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.03.055 · Cited by 8
Insights into the advances in therapeutic drugs for neuroinflammation-related diseases
Luo, B. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2260088 · Cited by 7
Neurobiochemical Disturbances in Psychosis and their Implications for Therapeutic Intervention
Panov, G., & Panova, P. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266282773240116073618 · Cited by 8
Zager, A., Brandão, W. N., Margatho, R. O., da Cruz, D. S. G., Peron, J. P. S., Tufik, S. B., Andersen, M. L., Moresco, M., Pizza, F., Plazzi, G., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.009 · Cited by 8
Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis
Gonçalves, E. C. D., Lieberknecht, V., Horewicz, V. V., Rabelo, B. D., Felipetti, F. A., Rodrigues, A. L. S., Martins, D. F., & Dutra, R. C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02507-6 · Cited by 8
Basova, L. V., Lindsey, A., McGovern, A., Gaskill, P. J., Rosander, A. M., Delorme-Walker, V., ElShamy, W. M., Pendyala, V. V., Ellis, R. J., Cherner, M., et al. (2023) · Viruses · doi:10.3390/v15061363 · Cited by 8
Regulation of inflammatory responses by the autonomic nervous system
SUZUKI, K. (2016) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.39.96 · Cited by 8
PKA Has the Gall to Oppose NLRP3
Groß, C. J., & Groß, O. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.019 · Cited by 8
Liu, Y., Qin, K., Jiang, C., Gao, J., Hou, B., & Xie, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04373-4 · Cited by 7
Galangin reduces MPTP-induced dopamine neuron injury via the autophagy dependent-PI3K/AKT pathway
Huang, L., Li, Q., Wu, J., He, Y., Huang, J., Xie, S., Yang, C., Ruan, Q., Zhou, Z., & Deng, M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1568002 · Cited by 7
Jiang, K., Zou, Y., Song, Y., Zhou, L., Zhang, B., Zhou, X., & Zhang, X. (2025) · Brain and Behavior · doi:10.1002/brb3.70379 · Cited by 6
Zou, Y., Zhang, B., Jiang, K., Zhou, X., Tang, Q.-K., Chen, S.-J., Wu, Q., Zhao, X., & Zhang, X. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116971 · Cited by 7
Li, Y.-T., Li, K. K.-H., Tao, S., Wang, T., Lu, Y., Chen, H., Zhan, Y., Zhao, K., Xiang, S., Li, J., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx3827 · Cited by 7
Walker, K. A., Rhodes, S. T., Liberman, D. A., Gore, A. C., & Bell, M. R. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.07.009 · Cited by 8
Huang, P., Zhu, Z., Li, W., Zhang, R., Chi, Y., & Gong, W. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00775-2 · Cited by 8
G protein-coupled receptors: A golden key to the treasure-trove of neurodegenerative diseases
Li, H., Qiao, Z., Xiao, X., Cao, X., Li, Z., Liu, M., Jiao, Q., Chen, X., Du, X., & Jiang, H. N. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.01.032 · Cited by 7
Dang, W., Xu, D., Xie, W., & Zhou, J. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4149-4 · Cited by 8
Vieira, É. L. M., da Silva, M. C. M., Gonçalves, A. P., Martins, G. L., Teixeira, A. L., de Oliveira, A. C. P., & Reis, H. J. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577534 · Cited by 7
Dopamine Receptors in the Gastrointestinal Tract
Zhang, X., Liu, S., Sun, Q., & Zhu, J. (2021) · Springer eBooks · doi:10.1007/978-981-33-6586-5_3 · Cited by 7
The role of macrophages in the development of neuroinflammation in multiple sclerosis
Melnikov, M., Sviridova, A. A., Rogovskii, V., Boyko, A. N., & Pashenkov, M. V. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212205151 · Cited by 7
Wang, T., Xiao, Y., Luo, R., Wang, Y., Zou, M., Sun, Y., Wang, L., Guo, Q., & Peng, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109419 · Cited by 7
Association of MARCH7 with tumor progression and T-cell infiltration in esophageal cancer
Singh, S., Bano, A., Saraya, A., Das, P., & Sharma, R. (2022) · Medical Oncology · doi:10.1007/s12032-022-01938-y · Cited by 7
Vines, L., Sotelo, D., Giddens, N. T., Manza, P., Volkow, N. D., & Wang, G. (2023) · Brain Sciences · doi:10.3390/brainsci13101480 · Cited by 7
Autonomic control of inflammation
Suzuki, K., & Nakai, A. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12292 · Cited by 7
LMP7 inhibits the activation of NLRP3 inflammasome through interaction with NLRP3
Jin, J., Wang, W., Li, A., & Wu, J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.091 · Cited by 7
Belousova, O., Lopatina, A., & Melnikov, M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112540 · Cited by 6
Kim, Y., Lee, S., & Park, Y. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169018 · Cited by 7
The LTB4-BLT1 axis attenuates influenza-induced lung inflammation by suppressing NLRP3 activation
Cheng, W., Xu, Y., Zheng, Y. Y., Hong, L., Lyu, C., Li, H., & Cao, B. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02450-8 · Cited by 6
Li, M., Zhang, C., Zhou, L., Sun, X., Wang, T., & Fu, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853834 · Cited by 6
Astrocytes: Role in pathogenesis and effect of commonly misused drugs in the HIV infected brain
Pla-Tenorio, J., Roig, A. M., García-Cesaní, P. A., Santiago, L. A., Sepulveda-Orengo, M. T., & Noel, R. J. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100108 · Cited by 6
A dopamine D1-like receptor-specific agonist improves the survival of septic mice
Tanaka, K., Choudhury, M. E., Kikuchi, S., Takeda, I., Umakoshi, K., Miyaue, N., Mikami, K., Takenaga, A., Yagi, H., Shinabe, R., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109587 · Cited by 6
Campos, J., Osorio‐Barrios, F., Villanelo, F., Gutiérrez-Maldonado, S. E., Vargas, P., Pérez‐Acle, T., & Pacheco, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810022 · Cited by 6
Shang, L., Yang, F., Chen, Q., Dai, Z., Yang, G., Zeng, X., Qiao, S., & Yu, H. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-024-01115-3 · Cited by 7
The promise of cyclic AMP modulation to restore cognitive function in neurodevelopmental disorders
Bhattacharya, A., Turkalj, L., & Manzini, M. C. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102966 · Cited by 6
The NLRP3 Inflammasome: A Possible Therapeutic Target for Treatment of Stroke
Ishrat, T., & Nasoohi, S. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-66679-2_22 · Cited by 5
Caspase 1 activity influences juvenile Batten disease ( CLN 3) pathogenesis
Burkovetskaya, M. E., Bosch, M. E., Karpuk, N., Fallet, R. W., & Kielian, T. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14480 · Cited by 7
Mul1 suppresses Nlrp3 inflammasome activation through ubiquitination and degradation of AscPreprint
Kim, J., Lee, Y., Suh, G. Y., & Lee, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/830380 · Cited by 6
Wang, J., Qiao, Z., Cao, X., Li, H., Wang, Y., Jiao, Q., Chen, X., & Du, X. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117303 · Cited by 5
Zhang, T., Du, H., & Wang, S. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s587802 · Cited by 5
A role of inflammasomes in the pathogenesis of neurological and mental diseases
Пирожков, С. В., Terebilina, N. N., & Litvitskiy, P. F. (2018) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201811812181 · Cited by 6
Hoen, E., Goossens, F. M., Falize, K., Mayerl, S. E., van der Spek, A. H., & Boelen, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042111 · Cited by 5
Metadata
- Authors
- Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R.
- Affiliations
- University of Science and Technology of China (CN)
- Beijing Proteome Research Center (CN)
- Corresponding author
- Tian, Zhigang
- Zhou, Rongbin
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 160
- Issue
- 1-2
- Pages
- 62-73
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2084158898
- Cited by
- 1,014
- References
- 49
- Citations by year
- 2026: 59 · 2025: 93 · 2024: 98 · 2023: 103 · 2022: 108 · 2021: 124 · 2020: 112 · 2019: 79 · 2018: 104 · 2017: 66 · 2016: 47 · 2015: 20
- FWCI
- 34.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81222040, 81330078)
- Ministry of Education of the People's Republic of China (20123402110010, 20123402120001)
- National Key Research and Development Program of China (2013CB944904, 2014CB910800)
- Fundamental Research Funds for the Central Universities
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- dopamine, NLRP3 inflammasome, dopamine D1 receptor, cAMP signaling, ubiquitination, inflammasome regulation, systemic inflammation, neuroinflammation, lipopolysaccharide-induced inflammation, peritonitis
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Cyclic AMP, Animals, Autophagy, Carrier Proteins, Dopamine, Inflammation, Mice, Inbred C57BL, Receptors, Dopamine, Signal Transduction, Receptors, Dopamine D1, Neurotransmitter Agents, Mice, Ubiquitination, Inflammasomes, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review